285 related articles for article (PubMed ID: 15749920)
1. IL-10-dependent suppression of experimental allergic encephalomyelitis by Th2-differentiated, anti-TCR redirected T lymphocytes.
Mekala DJ; Alli RS; Geiger TL
J Immunol; 2005 Mar; 174(6):3789-97. PubMed ID: 15749920
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy of autoimmune encephalomyelitis with redirected CD4+CD25+ T lymphocytes.
Mekala DJ; Geiger TL
Blood; 2005 Mar; 105(5):2090-2. PubMed ID: 15528313
[TBL] [Abstract][Full Text] [Related]
3. Activation of regulatory cells suppresses experimental allergic encephalomyelitis via secretion of IL-10.
Stohlman SA; Pei L; Cua DJ; Li Z; Hinton DR
J Immunol; 1999 Dec; 163(11):6338-44. PubMed ID: 10570329
[TBL] [Abstract][Full Text] [Related]
4. CD8+ T cells control the TH phenotype of MBP-reactive CD4+ T cells in EAE mice.
Jiang H; Braunstein NS; Yu B; Winchester R; Chess L
Proc Natl Acad Sci U S A; 2001 May; 98(11):6301-6. PubMed ID: 11353822
[TBL] [Abstract][Full Text] [Related]
5. Role of IL-12 receptor beta 1 in regulation of T cell response by APC in experimental autoimmune encephalomyelitis.
Zhang GX; Yu S; Gran B; Li J; Siglienti I; Chen X; Calida D; Ventura E; Kamoun M; Rostami A
J Immunol; 2003 Nov; 171(9):4485-92. PubMed ID: 14568921
[TBL] [Abstract][Full Text] [Related]
6. IL-10-dependent infectious tolerance after the treatment of experimental allergic encephalomyelitis with redirected CD4+CD25+ T lymphocytes.
Mekala DJ; Alli RS; Geiger TL
Proc Natl Acad Sci U S A; 2005 Aug; 102(33):11817-22. PubMed ID: 16087867
[TBL] [Abstract][Full Text] [Related]
7. Induction of resistance to active experimental allergic encephalomyelitis by myelin basic protein-specific Th2 cell lines generated in the presence of glucocorticoids and IL-4.
Ramírez F; Mason D
Eur J Immunol; 2000 Mar; 30(3):747-58. PubMed ID: 10741389
[TBL] [Abstract][Full Text] [Related]
8. Oral tolerance in myelin basic protein T-cell receptor transgenic mice: suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells.
Chen Y; Inobe J; Kuchroo VK; Baron JL; Janeway CA; Weiner HL
Proc Natl Acad Sci U S A; 1996 Jan; 93(1):388-91. PubMed ID: 8552644
[TBL] [Abstract][Full Text] [Related]
9. Redirecting therapeutic T cells against myelin-specific T lymphocytes using a humanized myelin basic protein-HLA-DR2-zeta chimeric receptor.
Moisini I; Nguyen P; Fugger L; Geiger TL
J Immunol; 2008 Mar; 180(5):3601-11. PubMed ID: 18292588
[TBL] [Abstract][Full Text] [Related]
10. A chimeric TCR-beta chain confers increased susceptibility to EAE.
Petersen TR; Lata R; Spittle E; Bäckström BT
Mol Immunol; 2007 Jul; 44(14):3473-81. PubMed ID: 17481734
[TBL] [Abstract][Full Text] [Related]
11. Oral tolerance to copolymer 1 in myelin basic protein (MBP) TCR transgenic mice: cross-reactivity with MBP-specific TCR and differential induction of anti-inflammatory cytokines.
Maron R; Slavin AJ; Hoffmann E; Komagata Y; Weiner HL
Int Immunol; 2002 Feb; 14(2):131-8. PubMed ID: 11809732
[TBL] [Abstract][Full Text] [Related]
12. A T helper cell 2 (Th2) immune response against non-self antigens modifies the cytokine profile of autoimmune T cells and protects against experimental allergic encephalomyelitis.
Falcone M; Bloom BR
J Exp Med; 1997 Mar; 185(5):901-7. PubMed ID: 9120396
[TBL] [Abstract][Full Text] [Related]
13. Induction or protection from experimental autoimmune encephalomyelitis depends on the cytokine secretion profile of TCR peptide-specific regulatory CD4 T cells.
Kumar V; Sercarz E
J Immunol; 1998 Dec; 161(12):6585-91. PubMed ID: 9862685
[TBL] [Abstract][Full Text] [Related]
14. 5-aminoimidazole-4-carboxamide ribonucleoside: a novel immunomodulator with therapeutic efficacy in experimental autoimmune encephalomyelitis.
Nath N; Giri S; Prasad R; Salem ML; Singh AK; Singh I
J Immunol; 2005 Jul; 175(1):566-74. PubMed ID: 15972693
[TBL] [Abstract][Full Text] [Related]
15. Suppression of ongoing experimental allergic encephalomyelitis (EAE) in Lewis rats: synergistic effects of myelin basic protein (MBP) peptide 68-86 and IL-4.
Xu LY; Huang YM; Yang JS; Van Der Meide PH; Link H; Xiao BG
Clin Exp Immunol; 2000 Jun; 120(3):526-31. PubMed ID: 10844533
[TBL] [Abstract][Full Text] [Related]
16. Copolymer 1 induces T cells of the T helper type 2 that crossreact with myelin basic protein and suppress experimental autoimmune encephalomyelitis.
Aharoni R; Teitelbaum D; Sela M; Arnon R
Proc Natl Acad Sci U S A; 1997 Sep; 94(20):10821-6. PubMed ID: 9380718
[TBL] [Abstract][Full Text] [Related]
17. Neonatal exposure to antigen primes the immune system to develop responses in various lymphoid organs and promotes bystander regulation of diverse T cell specificities.
Pack CD; Cestra AE; Min B; Legge KL; Li L; Caprio-Young JC; Bell JJ; Gregg RK; Zaghouani H
J Immunol; 2001 Oct; 167(8):4187-95. PubMed ID: 11591739
[TBL] [Abstract][Full Text] [Related]
18. Immunoregulation of encephalitogenic MBP-NAc1-11-reactive T cells by CD4+ TCR-specific T cells involves IL-4, IL-10 and IFN-gamma.
Adlard K; Tsaknardis L; Beam A; Bebo BF; Vandenbark AA; Offner H
Autoimmunity; 1999; 31(4):237-48. PubMed ID: 10789989
[TBL] [Abstract][Full Text] [Related]
19. Self-antigen-induced Th2 responses in experimental allergic encephalomyelitis (EAE)-resistant mice. Th2-mediated suppression of autoimmune disease.
Cua DJ; Hinton DR; Stohlman SA
J Immunol; 1995 Oct; 155(8):4052-9. PubMed ID: 7561116
[TBL] [Abstract][Full Text] [Related]
20. Specific T regulatory cells display broad suppressive functions against experimental allergic encephalomyelitis upon activation with cognate antigen.
Yu P; Gregg RK; Bell JJ; Ellis JS; Divekar R; Lee HH; Jain R; Waldner H; Hardaway JC; Collins M; Kuchroo VK; Zaghouani H
J Immunol; 2005 Jun; 174(11):6772-80. PubMed ID: 15905518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
